share_log

Pfizer's Duchenne Pain Seen As Sarepta's Gain -- Market Talk

Pfizer's Duchenne Pain Seen As Sarepta's Gain -- Market Talk

輝瑞治療肌肉萎縮性側索硬化症的疼痛,可能會使賽普拉公司受益 - 市場評論
WSJ ·  06/13 07:48

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論